Ontology highlight
ABSTRACT:
SUBMITTER: Yao Y
PROVIDER: S-EPMC10339369 | biostudies-literature | 2023 Jul
REPOSITORIES: biostudies-literature
Yao Yao Y Fan Bin B Yang Bin B Jia Zixuan Z Li Bao B
Journal of clinical hypertension (Greenwich, Conn.) 20230619 7
As the blood pressure threshold for commencing antihypertensive treatment diminishes, the cohort suffering from resistant hypertension (RH) correspondingly expands. Notwithstanding the availability of known antihypertensive medications, there exists a conspicuous lacuna in therapeutic options specifically intended for the management of RH. Currently, aprocitentan is the sole endothelin receptor antagonist (ERA) under development for addressing this pressing clinical challenge. Aprocitentan (ACT- ...[more]